Flashpoint Therapeutics

Flashpoint Therapeutics Develops Nanotechnology Therapies for Cancer and Other DiseasesFlashpoint Therapeutics develops nanotechnology-based therapies for cancer and other diseases. The company offers a design approach to cancer immunotherapy, transforming therapeutic components from inactive to active through optimized nanostructures. Its nanotechnology-based discovery platform enables more effective multi-targeted therapies by precisely controlling stoichiometry, optimizing structure-function relationships, and synchronizing activation kinetics to co-deliver diverse RNA, DNA, and peptide cargos to the right cells. Flashpoint Therapeutics has shown promise in treating breast cancer, lymphoma, cervical cancer, melanoma, colon cancer, glioma, and other cancers. Based on these studies, the company plans to advance the most promising drug candidates into clinical trials.